Table 3.
Cancer Diagnoses
| Cancer diagnosis | Living will n = 176 | Health care proxy n = 534 | No living will or health care proxy n = 411 |
|---|---|---|---|
| Thoracic | 14 (8.0%) | 57 (10.7%) | 50 (12.2%) |
| Gastrointestinal | 49 (27.8%) | 131 (24.5%) | 88 (21.4%) |
| Genitourinary | 27 (15.3%) | 79 (14.9%) | 66 (16.1%) |
| Head and Neck | 9 (5.1%) | 46 (8.6%) | 23 (5.6%) |
| Hematologic | 35 (19.9%) | 77 (14.4%) | 86 (20.9%) |
| HSCT | 19 (10.8%) | 44 (8.2%) | 24 (5.8%) |
| Miscellaneous | 19 (10.8%) | 85 (15.9%) | 57 (13.9%) |
| No cancer | 4 (2.3%) | 15 (2.8%) | 17 (4.1%) |
Thoracic (lung, mediastinal, thymoma, and mesothelioma); gastrointestinal (esophageal, gastric, small bowel, colorectal, pancreas, hepato-biliary and peritoneal); genitourinary (renal, bladder, urothelial, prostate, testicular, ovarian, uterine, cervical and vaginal); Head and neck (oral cavity, neck, sinuses, thyroid and parathyroid); hematologica (leukemia, lymphoma, myelodysplastic syndrome, multiple myeloma and amyloidosis); HSCT, hematopoietic stem cell transplantation (allogeneic or autologous); miscellaneous (breast, central nervous system, sarcoma, human immunodeficiency virus (HIV)-related, and unknown primary).